These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5678579)

  • 1. Effects of reserpine on brain and liver glycogen levels after pretreatment with pargyline in isolated and aggregated mice.
    Pfeifer AK; Fodor M
    Psychopharmacologia; 1968; 13(2):170-3. PubMed ID: 5678579
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
    Pfeifer AK; Galambos E
    Psychopharmacologia; 1967; 11(2):130-5. PubMed ID: 5588185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporation of [U-14 C]glucose into metabolites of brain, liver and blood of rats pretreated with reserpine or phenothiazines.
    Raheem KA; Gründig E; Salvenmoser F; Schedl R; Weiss J
    J Clin Chem Clin Biochem; 1979 Jun; 17(6):341-8. PubMed ID: 458382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histochemical study of the behaviour of the adrenal tissue and certain glycogen rich organs after treatment of chick embryos with parathion and reserpine].
    Meiniel R
    C R Seances Soc Biol Fil; 1971; 165(9):1918-21. PubMed ID: 4116488
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.
    Hutchins DA
    Br J Pharmacol; 1979 Mar; 65(3):489-94. PubMed ID: 427324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of reserpine on recovery rates after inhibition of monoamine oxidase in different regions of mouse brain.
    Hall TR; Yurgens PB; Figueroa HR
    Gen Pharmacol; 1984; 15(6):485-9. PubMed ID: 6526260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms controlling glycogen levels in injured brain, normal brain, liver, and heart.
    Guth L; Dempsey PJ
    Exp Neurol; 1970 Oct; 29(1):152-61. PubMed ID: 5478360
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of reserpine and pargyline on glutamate decarboxylase activity in rat hypothalamic nuclei.
    Itoh M; Uchimura H; Hirano M; Saito M; Nakahara T
    Brain Res; 1976 Oct; 115(3):529-34. PubMed ID: 1067888
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental studies on the variation of carbohydrate in the chicken. VI. Inhibitory effects of pentobarbital and reserpine upon the action of adrenaline on blood glucose, blood lactate, liver glycogen, and muscle glycogen].
    Nakatani Y
    Nihon Juigaku Zasshi; 1964 Apr; 26(2):91-8. PubMed ID: 5896563
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of amphetamine toxicity and tissue glycogen depletion in mice and rats.
    Stolk JM; Burnett LS; Rech RH
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):395-404. PubMed ID: 5453238
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and pargyline on levorphanol-induced running activity in mice.
    Hollinger M
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):419-24. PubMed ID: 5367312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the mechanism of the glycogenolytic action of nicotinic acid].
    Ammon HP; Estler CJ
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):214. PubMed ID: 4242371
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antagonistic action of pargyline with respect to reserpine hypothermia].
    Boissier JR; Simon P; Lwoff JM; Hertz F
    Therapie; 1966; 21(3):645-51. PubMed ID: 5942130
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcellular distribution of 5-hydroxytryptamine in rat brain during development: effect of drugs and fasting.
    Tissari AH; Raunu EM
    J Neurochem; 1975 Jun; 24(6):1143-50. PubMed ID: 1079237
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects induced by the interaction of reserpine with desipramine.
    Jori A; Annoni F; Bianchetti A
    J Pharm Pharmacol; 1968 Nov; 20(11):862-6. PubMed ID: 4387494
    [No Abstract]   [Full Text] [Related]  

  • 19. p-Chlorophenylalanine: a specific depletor of brain serotonin.
    Koe BK; Weissman A
    J Pharmacol Exp Ther; 1966 Dec; 154(3):499-516. PubMed ID: 5297133
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.
    Cascio CS; Kellar KJ
    Eur J Pharmacol; 1986 Jan; 120(1):101-5. PubMed ID: 3948908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.